Clinical Trials on Ankle Injuries and Disorders in Russian Federation

Total 1923 results

Pirogov Russian National Research Medical University

Unknown

Bendamustine and Rituximab (BR) as Induction and Maintenance in Relapsed and Refractory Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Russian Federation
Pfizer

Completed

Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone

Psychotic Disorders | Schizophrenia

Russian Federation, Canada
Abbott Nutrition

Completed

Effect of Nutritional Supplementation on Pediatric Burn Patients

Burns

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

MRI T2* Mapping of Myocardium, Liver, Pancreas and Pituitary Gland

Iron Overload

Russian Federation
Eli Lilly and Company

Completed

A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

Bipolar Depression

Russian Federation, United States
Oslo University Hospital
St. Petersburg State Pavlov Medical University

Completed

Individualized Nutrition for Adult Recipients of Allogeneic Stem Cell Transplants - Effect on Quality of Life (NASQ)

Effect of Individualized Nutrition on Quality of Life

Norway, Russian Federation
GlaxoSmithKline

Completed

Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)

Purpura, Thrombocytopaenic, Idiopathic

Germany, Russian Federation
Alisa Apreleva
ALS Centre Moscow

Unknown

Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS

ALS (Amyotrophic Lateral Sclerosis) | Dysphagia | Aspiration Pneumonia | Dyspnea | Breathlessness | Motor Neuron Disease, Amyotrophic Lateral Sclerosis | Hypernasality | Dysarthria, Flaccid | Dysarthria, Spastic | Dysarthria, Mixed

Russian Federation, United Kingdom
Bayer

Active, not recruiting

A Study to Gather Information About the Progress and Outcomes of Pregnancy in Women Using Various Vitamin Support Plans Before and During Pregnancy

Prevention of Vitamin Deficiency During and/or Before Pregnancy

Russian Federation, Kazakhstan, Uzbekistan
Tomsk National Research Medical Center of the Russian...

Completed

Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System (CTCs)

Breast Cancer | Ovarian Cancer | Endometrial Cancer

Russian Federation
Federal Research Institute of Pediatric Hematology...

Active, not recruiting

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis

Myelodysplastic Syndromes | Juvenile Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia | Myeloblastic Leukemia | Malignant Lymphoma | Biphenotypic Acute Leukemia

Russian Federation
Baxalta now part of Shire

Completed

Pharmacokinetic Study of ADVATE 3000 IU in Previously Treated Patients With Severe Hemophilia A

Hemophilia A

Bulgaria, Russian Federation
Ryazan State Medical University

Completed

Associations of Combinations of Single-nucleotide Polymorphisms in Women With Premature Ovarian Failure

Cardiovascular Diseases | Coronary Disease | Arrhythmias, Cardiac | Primary Ovarian Insufficiency | Menopause, Premature | Pulmonary Embolism | Polymorphism, Single Nucleotide

Russian Federation
Institute of Biomedical Chemistry, Russia

Completed

"Phospholipovit" vs Placebo in Patients With Combined Hyperlipidemia

Combined Hyperlipidemia

Russian Federation
University of Oklahoma
Centers for Disease Control and Prevention

Completed

Development of Education Materials for Prevention of FAS in Russia

Fetal Alcohol Spectrum Disorders | Fetal Alcohol Syndrome (FAS) | Alcohol Related Neurodevelopmental Disorder | Alcohol Use Complicating Pregnancy, Unspecified Trimester

United States, Russian Federation
Rovi Pharmaceuticals Laboratories

Completed

Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths (PRISMA-1)

Schizophrenia | Schizoaffective Disorder

Spain, South Africa, Russian Federation, Croatia
Valenta Pharm JSC

Recruiting

Efficacy and Safety of Vespireit, Sustained-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo

Vertigo | Autonomic Dysfunction

Russian Federation
Moscow City Oncology Hospital No. 62

Completed

[SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer (SENTRY)

Endometrial Neoplasms | Endometrial Cancer | Sentinel Lymph Node | Endometrial Endometrioid Adenocarcinoma | Endometrial Adenocarcinoma | Hysterectomy | Endometrial Cancer Stage I | Laparoscopic Hysterectomy | Endometrial Cancer Stage II

Russian Federation
Sanofi

Completed

An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients (FIDELIO)

Major Depressive Disorder

Romania, Russian Federation, Ukraine, Mexico, Slovakia, Chile, South Africa
Octapharma

Completed

Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases

Primary Immune Deficiency Disorder

Russian Federation
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral Atherosclerosis

Cerebral Atherosclerosis

Russian Federation
Clinical Institute of the Brain, Russia

Unknown

Comprehensive Reparative Therapy in Ischemic Stroke COMplex Repair in Ischemic Stroke-Arm

Ischemic Stroke

Russian Federation
Russian Academy of Medical Sciences

Completed

Navigation Repetitive Transcranial Magnetic Stimulation in Stroke Rehabilitation (NTMSR)

Stroke

Russian Federation
New York University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Computer-based Intervention for Alcohol-using HIV/HCV+ Women

Hepatitis C | Human Immunodeficiency Virus | Alcohol Abuse

United States, Russian Federation
AstraZeneca

Recruiting

hATTR Polyneuropathy in Russia (PRIMER)

Hereditary Transthyretin Amyloidosis

Russian Federation
AO GENERIUM

Completed

Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNH

Paroxysmal Nocturnal Hemoglobinuria | Marchiafava-Micheli Syndrome | Paroxysmal Hemoglobinuria

Russian Federation
R-Pharm International, LLC
R-Pharm; Atlant Clinical LLC; Unimed Laboratories CJSC; Data Management 365; Center...

Recruiting

Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine

Familial Mediterranean Fever | FMF

Armenia, Georgia, Russian Federation
AstraZeneca

Completed

Retrospective Observational Study DIANA Study (DIANA)

Major Depressive Episode

Russian Federation
Astana Medical University

Unknown

"The Effect of Comprehensive Non-pharmacological Treatment on Metabolic Disorders in Type 2 Diabetic Patients"

Type 2 Diabetes

Kazakhstan, Russian Federation
Sandoz

Completed

Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia.

Mild and Moderate Iron-deficiency Anaemia

Russian Federation
Bio Products Laboratory

Completed

An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery

Haemophilia B

Poland, Romania, Russian Federation
I.M. Sechenov First Moscow State Medical University

Completed

Clinical and Neurophysiological Characteristics of Narcolepsy

Narcolepsy Type 1

Russian Federation
Russian Academy of Medical Sciences
Blokhin's Russian Cancer Research Center

Recruiting

Atypical MOLes and Melanoma Early Detection Study (MoleMed) (MoleMed)

Melanoma | Nevus | Nevus, Pigmented | Melanoma (Skin) | Mucosal Melanoma | Moles | Dysplastic Nevus Syndrome | Nevus, Blue | Nevus, Spitz | Nevi, Spindle Cell | Nevi, Dysplastic | Mucosal Melanosis

Russian Federation
Enrollme.ru, LLC
Danone Nutricia

Completed

Study to Assess the Effect of ONS Nutridrink® 200 ml on the Recovery of Patients With COVID-19 and Respiratory Support

COVID-19

Russian Federation
Catalyst Biosciences

Completed

Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia

Hemophilia A | Hemophilia B | Hemophilia A With Inhibitor | Hemophilia B With Inhibitor | Hemophilia A Without Inhibitor | Hemophilia B Without Inhibitor

Bulgaria, Russian Federation
CSL Behring
Parexel

Completed

Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease

Von Willebrand Disease

Bulgaria, Poland, Russian Federation, Ukraine
H. Lundbeck A/S

Completed

Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder

Major Depressive Disorder

Austria, Russian Federation
NewVac LLC
Janssen Pharmaceutica N.V., Belgium

Completed

Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Ovarian Cancer

Russian Federation
Hoffmann-La Roche

Completed

A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment

Diabetes Mellitus Type 2

United States, Russian Federation
Materia Medica Holding

Completed

Efficacy and Safety of Tenoten for Children in the Treatment of Specific Developmental Disorders of Scholastic Skills in Children

Specific Developmental Disorders of Scholastic Skills

Russian Federation
Ural State Medical University
Ural Institute of Cardiology; De Haar Research Foundation

Terminated

Ranibizumab and the Risk of Arterial Thromboembolic Events (RATE)

Coronary Artery Disease | Cerebrovascular Disorders | Age-related Macular Degeneration

Netherlands, Russian Federation
Sanofi

Completed

An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder (LENA)

Depressive Disorder

Canada, Russian Federation, Bulgaria, Mexico, Argentina, Chile, Croatia
Novartis Pharmaceuticals

Completed

This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.

Myelodysplastic Syndrome | Thalassemia

Russian Federation
Ivix LLX

Completed

Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire

Hypoactive Sexual Desire Disorder (HSDD)

Russian Federation
AO GENERIUM

Recruiting

A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II

Metabolic Diseases | Mucopolysaccharidosis Type II

Russian Federation
AstraZeneca

Completed

A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia (RECONNECT-S)

Schizophrenia

Russian Federation
AO GENERIUM

Completed

Observational Study of Elizaria® in aHUS Patients

Atypical Hemolytic Uremic Syndrome | aHUS

Russian Federation
ChemRar Research and Development Institute, LLC

Completed

А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder

Anxiety Disorder Generalized

Russian Federation
Mikhail Zykov

Recruiting

Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During Hospitalization (COLCHIDA)

Ischemic Stroke

Russian Federation
Central Clinical Hospital of the Russian Academy...
Ural State Medical University; De Haar Research Task Force; De Haar Research... and other collaborators

Terminated

Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomography Angiography in Comparison With Invasive Multimodality Imaging (REALITY)

Coronary Artery Disease | Alzheimer Disease | Contrast-induced Nephropathy | Coronary Atherosclerosis | Cerebrovascular Disease | Stable Chronic Angina | Chronic Coronary Insufficiency

Netherlands, Russian Federation, Estonia

Clinical Trials on Ankle Injuries and Disorders in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations